Euro

Search documents
欧元信用债市场发行量激增
Jin Tou Wang· 2025-07-07 02:44
这一现象主要受到三方面因素驱动:首先,机构投资者对信用债资产的配置需求持续强劲,为一级市场 提供了充足的资金支持;其次,企业发行人普遍选择在二季度财报静默期到来前完成融资,以规避在此 期间发行新证券的监管限制;第三,随着7月9日美国关税政策最后期限临近,发债主体纷纷采取"未雨 绸缪"策略,通过提前锁定融资来应对可能出现的贸易政策变动风险。市场分析人士指出,当前欧元区 企业债发行窗口呈现"供需两旺"特征。一方面,在欧央行维持宽松货币政策的背景下,投资者对收益相 对较高的信用债品种保持旺盛需求;另一方面,发行人则充分利用有利的市场环境进行主动负债管理, 既满足了常规运营资金需求,也为潜在的贸易环境变化做好了流动性储备。值得注意的是,部分跨国企 业明显加快了欧元债券的发行节奏,反映出市场参与者对地缘政治风险的高度警觉。 从日线图观察,MACD指标来看,欧元兑美元MACD线与信号线(DEA)依旧处于0轴上方,显示趋势性 上涨动能未被破坏,MACD柱状图虽略有收敛迹象,仍在正区间,后续关注柱状图能否持续放大以支撑 价格上行。相对强弱指数(RSI)则运行在73.28,已进入超买区间,并出现回落迹象,显示短线多头力量 或有 ...
获批FDA!全球首个免缝合周围神经修复平台
思宇MedTech· 2025-07-04 08:37
招商通知 第三届全球手术机器人大会 第二届全球医疗科技大会 近日, Tissium公司 宣布其自主研发的 Coaptium Connect神经接合系统与Tissium Light光固化平台 获得 美国食品药品监督管理局(FDA)市场准入许可 。这是自 2007年以来 FDA首次批准基于新型聚合物平台的医疗设备 ,标志着Tissium在组织修复领域的重大突破。 Tissium 联合创始人兼首席执行官 Christophe Bancel 表示:"FDA 的上市许可验证了十多年来对开发下一代组织重建解决方案的科学和临床承诺。Coaptium Connect 是我们聚合物平台变革潜力的首次展示,也是为患者提供无创组织修复的重要一步。" # 关于 Coaptium Connect Coaptium Connect 是Tissium公司开发的一种 无创伤、无缝合的周围神经修复系统 ,结合了Tissium Light技术。具有以下特点: 无缝合设计 :Coaptium Connect通过 光激活的生物可吸收外科聚合物和3D打印的聚合物保护腔实现神经连接 ,消除了传统显微缝合的需求,从而降低瘢痕 形成和额外创伤的风险。 生物 ...
摩根大通:全球利率、大宗商品、货币及新兴市场展望和策略
摩根· 2025-07-04 01:35
Global Macro Research June 30th, 2025 Global Macro Outlook and Strategy Global Rates, Commodities, Currencies and Emerging Markets Luis Oganes AC (44-20) 7742-1420 luis.oganes@jpmorgan.com J.P. Morgan Securities plc See the end pages of this presentation for analyst certification and important disclosures. {[{xTcfaSlj-ZSQMv-ljRpIMwb8de_IkRyUQgSEehgsqRWyU9rJnLYnzA}]} Overall summary US Rates While we continue to find value at the front-end, front-end yields have declined to 2-month lows, aided in part by cri ...
Life Beyond Earth: Science Fiction or Reality? | Anezina Solomonidou | TEDxPatras
TEDx Talks· 2025-07-01 15:56
[Music] [Applause] Anybody here a fan of Star Wars, Interstellar, Men in Black, X-Files? I thought so. Very good audience. Thank you. Is life beyond Earth a story we tell ourselves? Science fiction or it could be part of our reality just beyond our instruments and understanding. Imagine we are all now sitting in a spaceship as we do every morning. Right? For those of you who haven't done so yet, please fasten your seat belts. The countdown is about to begin. Imagine where would you like to go and input your ...
Stryker to announce financial results for its second quarter of fiscal year 2025
GlobeNewswire News Room· 2025-07-01 12:00
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, July 31, 2025, to discuss its ...
Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock
Globenewswire· 2025-07-01 01:45
Group 1 - Dyne Therapeutics, Inc. announced a public offering of 24,242,425 shares of common stock at a price of $8.25 per share, aiming for gross proceeds of $200 million before expenses [1] - The offering is expected to close around July 2, 2025, pending customary closing conditions [1] - Dyne has granted underwriters a 30-day option to purchase an additional 3,636,363 shares at the public offering price [1] Group 2 - The offering is conducted under a shelf registration statement filed with the SEC on March 5, 2024, which became effective upon filing [3] - A preliminary prospectus supplement has been filed with the SEC, and a final prospectus will also be filed [3] Group 3 - Dyne Therapeutics focuses on developing therapeutics for genetically driven neuromuscular diseases, including myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) [5] - The company is also advancing preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease [5]
X @Bloomberg
Bloomberg· 2025-06-30 10:42
Turkey’s bid to buy Eurofighter Typhoon jets has won support from all consortium members, the UK said, raising prospects for a deal previously blocked by Germany https://t.co/biQY4uP7jr ...
Ophævelse af suspension
Globenewswire· 2025-06-30 09:30
Det skal oplyses, at suspension af nedenstående afdeling nu er ophævet, som følge af fusion, hvorfor det igen er muligt at handle i afdelingen. ISINDK0010265693AfdelingEuropean Stars KL Med venlig hilsenNordea Fund Management, filial af Nordea Funds Oy, Finland Rasmus Eske BruunFilialbestyrer ...
外媒:挪威博彩公司闹乌龙,数千人收到中百万大奖通知
Huan Qiu Wang· 2025-06-30 09:23
【环球网报道 记者 赵建东】数千名挪威人被博彩公司告知中了数百万的彩票大奖,但几小时后发现博彩 公司闹了乌龙,众人空欢喜一场。据英国《卫报》29日报道,挪威国营博彩公司Norsk Tipping 27日因人为 操作失误,错误通知数千名客户赢得"Eurojackpot"彩票的巨额奖金。Norsk Tipping首席执行官萨格斯图恩 于29日为此事道歉并宣布辞职。 《卫报》称,该公司在26日的声明中称:"数千名客户收到了错误的巨额中奖通知",此次事故根源在于欧 元兑挪威克朗汇率换算环节,出现人为输入编码错误,本应除以100的金额被乘以100,致使该公司的网站 和手机应用上显示虚增百倍的奖金额,后被紧急撤下,公司也确认未支付错误奖金。 这场"大奖乌龙"引发民众愤怒,挪威文化大臣及监管机构对乌龙事件提出严厉批评。报道称,挪威文化部 28日与Norsk Tipping公司举行紧急会议。多位挪威民众向当地媒体称,他们在收到中奖信息后已经开始庆 祝:赫罗伊市的一对夫妇在装修房屋时误以为中了120万挪威克朗(约85.4万人民币);还有民众计划购车 或去度假;丽莎·诺斯特达尔以为自己斩获190万挪威克朗(约135万人民币)后感 ...
Aker Solutions and Cognizant Renew Collaboration to Drive IT Transformation with AI-First Approach
Prnewswire· 2025-06-30 06:00
The new agreement seeks to modernize Aker Solutions' IT infrastructure using AI platforms, including Cognizant Neuro® platform. OSLO, Norway, June 30, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) and Aker Solutions, a global leader from Norway in the energy industry, have extended their long-lasting partnership, which began in 2016, with a new multi-year agreement. Using the Cognizant Neuro® platform, designed to boost generative AI adoption with flexibility, security, scalability, and responsibility, this ...